Bibliography
- Geisbert TW , PushkoP, AndersonK, SmithJ, DavisKJ, JahrlingPB: Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg. Infect. Dis8(5), 503–507 (2002).
- Volchkov VE , VolchkovaVA, MuhlbergerEet al.: Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.Science291(5510), 1965–1969 (2001).
- Enterlein S , VolchkovV, WeikMet al.: Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30.J. Virol.80(2), 1038–1043 (2006).
- Hevey M , NegleyD, PushkoP, SmithJ, SchmaljohnA: Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology251(1), 28–37 (1998).
- Olinger GG , HartMK: Protective immunity to Ebola infection by Venezuelian equine encephalitis virus replicons expressing Ebola virus proteins.Abstracts of the ICID Global Symposium. Filoviruses: Recent Advances and Future Challenges. International Centre for Infectious Diseases, Winnipeg, Canada, 17–19 September 2006.
- Sullivan NJ , SanchezA, RollinPE, YangZY, NabelGJ: Development of a preventive vaccine for Ebola virus infection in primates. Nature408(6812), 605–609 (2000).
- Sullivan NJ , GeisbertTW, GeisbertJBet al.: Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.Nature424(6949), 681–684 (2003).
- Sullivan NJ , GeisbertTW, GeisbertJBet al.: Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.PLoS Med.3(6), E177 (2006).
- Garbutt M , LiebscherR, Wahl-JensenVet al.: Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J. Virol.78(10), 5458–5465 (2004).
- Jones SM , FeldmannH, StroherUet al.: Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.Nat. Med.11(7), 786–790 (2005).
- Feldmann H , JonesSM, Daddario-DiCaprioKMet al.: Effective post-exposure treatment of Ebola infection.PLoS Pathog.3(1), e2 (2007).
- Daddario-DiCaprio KM , GeisbertTW, StroherUet al.: Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.Lancet367(9520), 1399–1404 (2006).
- Johnson E , JaaxN, WhiteJ, JahrlingP: Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.Int. J. Exp. Pathol.76(4), 227–236 (1995).
- Sergeev AN , LubM, P'IankovaOG, KotliarovLA: The efficacy of the emergency prophylactic and therapeutic actions of immunomodulators in experimental filovirus infections.Antibiot. Khimioter.40(5), 24–27 (1995).
- Pokhodiaev VA , GoncharNI, PshenichnovVA: An experimental study of the contact transmission of the Marburg virus.Vopr. Virusol.36(6), 506–508 (1991).
- Jaax N , JahrlingP, GeisbertTet al.: Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory.Lancet346(8991–8992), 1669–1671 (1995).
- Bukreyev A , YangL, ZakiSRet al.: A single intranasal inoculation with a Paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge.J. Virol.80(5), 2267–2279 (2006).
- Bukreyev A , RollinPE, TateMKet al.: Successful topical respiratory tract immunization of primates against Ebola virus.J. Virol.81(12), 6379–6388 (2007).
- Geigenmuller-Gnirke U , WeissB, WrightR, SchlesingerS: Complementation between Sindbis viral RNAs produces infectious particles with a bipartite genome.Proc. Natl Acad. Sci. USA88(8), 3253–3257 (1991).
- Yang ZY , WyattLS, KongWP, MoodieZ, MossB, NabelGJ: Overcoming immunity to a viral vaccine by DNA priming before vector boosting.J. Virol.77(1), 799–803 (2003).
- Quiroz E , MorenoN, PeraltaPH, TeshRB: A human case of encephalitis associated with vesicular stomatitis virus (Indiana serotype) infection. Am. J. Trop. Med. Hyg.39(3), 312–314 (1988).
- Pushko P , ParkerM, LudwigGV, DavisNL, JohnstonRE, SmithJF: Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.Virology239(2), 389–401 (1997).
- Clarke DK , NasarF, LeeMet al.: Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.J. Virol.81(4), 2056–2064 (2007).
- Kobinger GP , FeldmannH, ZhiYet al.: Chimpanzee adenovirus vaccine protects against Zaire Ebola virus.Virology346(2), 394–401 (2006).
- Stanford MM , McFaddenG, KarupiahG, ChaudhriG: Immunopathogenesis of poxvirus infections: forecasting the impending storm.Immunol. Cell Biol.85(2), 93–102 (2007).
- Thompson JM , WhitmoreAC, KonopkaJLet al.: Mucosal and systemic adjuvant activity of alphavirus replicon particles.Proc. Natl Acad. Sci. USA103(10), 3722–3727 (2006).
- Moran TP , CollierM, McKinnonKP, DavisNL, JohnstonRE, SerodyJS: A novel viral system for generating antigen-specific T cells. J. Immunol.175(5), 3431–3438 (2005).
- Warfield KL , BosioCM, WelcherBCet al.: Ebola virus-like particles protect from lethal Ebola virus infection.Proc. Natl Acad. Sci. USA100(26), 15889–15894 (2003).
- Warfield KL , SwensonDL, OlingerGG, AmanMJ, BavariS: Virus-like particle-based vaccines protect nonhuman primates against lethal Ebola virus infection.Abstracts of the ICID Global Symposium. Recent Advances and Future Challenges. International Centre for Infectious Diseases, Winnipeg, Canada, 17–19 September 2006.